Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. — Natural Product Compound Library | Innovative Drug Discovery | Spectral Intelligence | Micro-ED Analysis

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd. Healthy Roots Biotechnology (Shenzhen) Co., Limited Joint Development

中文 EN

Home

Products

NP Database

Services

Tech Insights

About

Contact

中文 EN

Plant Sources

Structural Classes

Microbial Sources

Flagship Varieties

Synthetic Compounds

CAS No.	NAME	Molecular Formula	Molecular Weight	Purity	Price	2D Structure
1784751-18-3	4-[2-(2,6-difluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]pyridine C1=CC(=C(C(=C1)F)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)F	C₂₀H₁₂F₃N₃	351.3	98%	Click to inquire
1784751-19-4	4-[2-(2-fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]pyridine C1=CC=C(C(=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC=C(C=C4)F)F	C₂₀H₁₃F₂N₃	333.3	98%	Click to inquire
178614-85-2	(R)-benzyl 4-isopropyl-2,5-dioxooxazolidine-3-carboxylate CC(C)C1C(=O)OC(=O)N1C(=O)OCC2=CC=CC=C2	C₁₄H₁₅NO₅	277.27	98%	Click to inquire
178616-26-7	1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one COC1=C(C=C2C(=C1)CC(=O)NN=C2C3=CC=C(C=C3)N)OC	C₁₇H₁₇N₃O₃	311.33	98%	Click to inquire
179068-02-1	Phccc C1C2C1(OC3=CC=CC=C3C2=NO)C(=O)NC4=CC=CC=C4	C₁₇H₁₄N₂O₃	294.30	99%	Click to inquire
179107-93-8	4-Bromo-5-((4-hydroxyphenethylamino)methyl)-2-methoxyphenol COC1=C(C=C(C(=C1)Br)CNCCC2=CC=C(C=C2)O)O	C₁₆H₁₈BRNO₃	352.22	98%	Click to inquire
179248-59-0	Src Kinase Inhibitor I COC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=C(C=C3)OC4=CC=CC=C4)OC	C₂₂H₁₉N₃O₃	373.4	99%	Click to inquire
179323-60-5	1-(Pyrazin-2-yl)ethanamine CC(C1=NC=CN=C1)N	C₆H₉N₃	123.16	98%	Click to inquire
179411-93-9	SDZ 220-581 hydrochloride C1=CC=C(C(=C1)C2=CC(=CC(=C2)CP(=O)(O)O)CC(C(=O)O)N)Cl.Cl	C₁₆H₁₈Cl₂NO₅P	406.2	96%	Click to inquire
179411-94-0	SDZ 220-581 Ammonium salt C1=CC=C(C(=C1)C2=CC(=CC(=C2)CP(=O)(O)O)CC(C(=O)O)N)Cl.N	C₁₆H₂₀ClN₂O₅P	386.77	98%	Click to inquire

4-[2-(2,6-difluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]pyridine

C₂₀H₁₂F₃N₃ 351.3

4-[2-(2-fluorophenyl)-4-(4-fluorophenyl)-1H-imidazol-5-yl]pyridine

C₂₀H₁₃F₂N₃ 333.3

(R)-benzyl 4-isopropyl-2,5-dioxooxazolidine-3-carboxylate

3-Oxazolidinecarboxylic acid, 4-(1-methylethyl)-2,5-dioxo-, phenylmethyl ester, (R)-

C₁₄H₁₅NO₅ 277.27

1-(4-Aminophenyl)-7,8-dimethoxy-3,5-dihydro-2,3-benzodiazepin-4-one

C₁₇H₁₇N₃O₃ 311.33

C₁₇H₁₄N₂O₃ 294.30

4-Bromo-5-((4-hydroxyphenethylamino)methyl)-2-methoxyphenol

4-bromo-5-((4-hydroxyphenethylamino)methyl)-2-methoxyphenol

C₁₆H₁₈BRNO₃ 352.22

Src Kinase Inhibitor I

Src Inhibitor 1

C₂₂H₁₉N₃O₃ 373.4

1-(Pyrazin-2-yl)ethanamine

1-PYRAZIN-2-YL-ETHYLAMINE

C₆H₉N₃ 123.16

SDZ 220-581 hydrochloride

SDZ 220-581 (hydrochloride)

C₁₆H₁₈Cl₂NO₅P 406.2

SDZ 220-581 Ammonium salt

SDZ 220-581 (Ammonium salt)

C₁₆H₂₀ClN₂O₅P 386.77

< Previous 1 2 3 4 5 6 7 8 9 10 ... (Current page 15295) 16106 Next >

All products and services are for scientific research only. They may not be used for human administration, nor are they supplied to individual consumers.

Address: Room B410, Virtual University Park Key Laboratory Building, No. 1 Yuexing 2nd Road, High-Tech Zone Community, Yuehai Subdistrict, Nanshan District, Shenzhen

Phone: 400-856-5689

Email: kehuaai@kehuaai.com

Kehua AI (Shenzhen) Innovative Drug R&D Co., Ltd.

ICP Record No.: 粤ICP备2024241782号